Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Drug-Induced Fulminant Hepatitis in a Child Treated for Latent Multidrug-Resistant Tuberculosis With Dual Therapy Combining Pyrazinamide and Levofloxacin.

Huguet A, Ader F, Ohlmann C, Collardeau-Frachon S, Gillet Y.

Pediatr Infect Dis J. 2019 Jul 15. doi: 10.1097/INF.0000000000002413. [Epub ahead of print]

PMID:
31335574
2.

FLNC pathogenic variants in patients with cardiomyopathies: Prevalence and genotype-phenotype correlations.

Ader F, De Groote P, Réant P, Rooryck-Thambo C, Dupin-Deguine D, Rambaud C, Khraiche D, Perret C, Pruny JF, Mathieu-Dramard M, Gérard M, Troadec Y, Gouya L, Jeunemaitre X, Van Maldergem L, Hagège A, Villard E, Charron P, Richard P.

Clin Genet. 2019 Oct;96(4):317-329. doi: 10.1111/cge.13594. Epub 2019 Jul 18.

PMID:
31245841
3.

Slowly or non-resolving Legionnaires' disease: case series and literature review.

Pouderoux C, Ginevra C, Descours G, Ranc AG, Beraud L, Boisset S, Magand N, Conrad A, Bergeron-Lafaurie A, Jarraud S, Ader F.

Clin Infect Dis. 2019 Jun 26. pii: ciz538. doi: 10.1093/cid/ciz538. [Epub ahead of print]

PMID:
31242293
4.

Parameters influencing the pharmacokinetics/pharmacodynamics of piperacillin/tazobactam in patients with febrile neutropenia and haematological malignancy: a prospective study.

Benech N, Dumitrescu O, Conrad A, Balsat M, Paubelle E, Ducastelle-Lepretre S, Labussière-Wallet H, Salles G, Cohen S, Goutelle S, Ader F; Lyon HEMINF Study Group .

J Antimicrob Chemother. 2019 Sep 1;74(9):2676-2680. doi: 10.1093/jac/dkz248.

PMID:
31219562
5.

Subcultured Mycobacterium tuberculosis isolates on different growth media are fully representative of bacteria within clinical samples.

Genestet C, Hodille E, Westeel E, Ginevra C, Ader F, Venner S, Lina G, Bryant JE, Berland JL, Dumitrescu O; Lyon TB study group.

Tuberculosis (Edinb). 2019 May;116:61-66. doi: 10.1016/j.tube.2019.05.001. Epub 2019 May 9.

PMID:
31153520
6.

UL23, UL30, and UL5 characterization of HSV1 clinical strains isolated from hematology department patients.

Labrunie T, Ducastelle S, Domenech C, Ader F, Morfin F, Frobert E.

Antiviral Res. 2019 Aug;168:114-120. doi: 10.1016/j.antiviral.2019.05.012. Epub 2019 May 30.

PMID:
31152759
7.

[Graft failure after allogeneic hematopoietic stem cell transplantation: Definition and risk factors].

Alcazer V, Peffault de Latour R, Ader F, Labussière-Wallet H.

Bull Cancer. 2019 Jun;106(6):574-583. doi: 10.1016/j.bulcan.2019.03.009. Epub 2019 May 4. Review. French.

PMID:
31060736
8.

Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018.

Genestet C, Tatai C, Berland JL, Claude JB, Westeel E, Hodille E, Fredenucci I, Rasigade JP, Ponsoda M, Jacomo V, Vachée A, Gaudart A, Gaillard JL, Roux AL, Ader F, Tararbit K, Terpant G, Bryant JE, Lina G, Dumitrescu O; Lyon TB Study Group.

Emerg Infect Dis. 2019 Mar;25(3):589-592. doi: 10.3201/eid2503.181124.

9.

VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients.

Conrad A, Boccard M, Valour F, Alcazer V, Tovar Sanchez AT, Chidiac C, Laurent F, Vanhems P, Salles G, Brengel-Pesce K, Meunier B, Trouillet-Assant S, Ader F; Lyon HEMINF Study Group.

BMJ Open. 2019 Feb 15;9(2):e026093. doi: 10.1136/bmjopen-2018-026093.

10.

Early-onset severe infections in allogeneic hematopoietic stem cell transplantation recipients with graft failure.

Alcazer V, Conrad A, Valour F, Bachy E, Salles G, Huynh A, de Latour RP, Labussière-Wallet H, Ader F.

Am J Hematol. 2019 Apr;94(4):E109-E111. doi: 10.1002/ajh.25406. Epub 2019 Feb 4. No abstract available.

PMID:
30663089
11.

Monomicrobial necrotising soft tissue infection of the hand caused by a Panton-Valentine leukocidin-negative Staphylococcus aureus strain in a 66-year-old patient with diabetes.

Furnon C, Ader F, Ferry T, Conrad A.

BMJ Case Rep. 2019 Jan 17;12(1). pii: e226501. doi: 10.1136/bcr-2018-226501. No abstract available.

PMID:
30659002
12.

External validation of risk factors for malignant ventricular arrhythmias in lamin A/C mutation carriers.

Thuillot M, Maupain C, Gandjbakhch E, Waintraub X, Hidden-Lucet F, Isnard R, Ader F, Rouanet S, Richard P, Charron P.

Eur J Heart Fail. 2019 Feb;21(2):253-254. doi: 10.1002/ejhf.1384. Epub 2019 Jan 9. No abstract available.

PMID:
30623531
13.

A practical approach to tuberculosis diagnosis and treatment in liver transplant recipients in a low-prevalence area.

Bosch A, Valour F, Dumitrescu O, Dumortier J, Radenne S, Pages-Ecochard M, Chidiac C, Ferry T, Perpoint T, Miailhes P, Conrad A, Goutelle S, Ader F; Lyon TB study Group.

Med Mal Infect. 2019 Jun;49(4):231-240. doi: 10.1016/j.medmal.2018.11.013. Epub 2018 Dec 24. Review.

PMID:
30591271
14.

A retrospective study of factors associated with treatment decision for nontuberculous mycobacterial lung disease in adults without altered systemic immunity.

Provoost J, Valour F, Gamondes D, Roux S, Freymond N, Perrot E, Souquet PJ, Kiakouama-Maleka L, Chidiac C, Lina G, Dumitrescu O, Sénéchal A, Ader F.

BMC Infect Dis. 2018 Dec 14;18(1):659. doi: 10.1186/s12879-018-3559-x.

15.

Targeted panel sequencing in adult patients with left ventricular non-compaction reveals a large genetic heterogeneity.

Richard P, Ader F, Roux M, Donal E, Eicher JC, Aoutil N, Huttin O, Selton-Suty C, Coisne D, Jondeau G, Damy T, Mansencal N, Casalta AC, Michel N, Haentjens J, Faivre L, Lavoute C, Nguyen K, Tregouët DA, Habib G, Charron P.

Clin Genet. 2019 Mar;95(3):356-367. doi: 10.1111/cge.13484. Epub 2018 Dec 27.

16.

[Genotype-phenotype correlations of pathogenic variants in the FLNC gene].

Ader F, Villard E, Ledeuil C, Charron P, Richard P.

Med Sci (Paris). 2018 Nov;34 Hors série n°2:39-41. doi: 10.1051/medsci/201834s211. Epub 2018 Nov 12. French. No abstract available.

PMID:
30418145
17.

Antituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Mycobacterium tuberculosis-infected macrophages.

Genestet C, Bernard-Barret F, Hodille E, Ginevra C, Ader F, Goutelle S, Lina G, Dumitrescu O; Lyon TB study group.

Tuberculosis (Edinb). 2018 Jul;111:67-70. doi: 10.1016/j.tube.2018.05.014. Epub 2018 May 22.

PMID:
30029917
18.

Severe laryngeal and pulmonary tuberculosis under anti-TNF-α therapy.

Bosch A, Conrad A, Fuchsmann C, Prot B, Dumitrescu O, Ferry T, Chidiac C, Ader F, Valour F; Lyon TB Study Group.

Int J Infect Dis. 2018 Jun;71:65-66. doi: 10.1016/j.ijid.2018.04.797. Epub 2018 Apr 24. No abstract available.

19.

Comment on: MIC-based dose adjustment: facts and fables.

Goutelle S, Genestet C, Ader F, Lina G, Dumitrescu O.

J Antimicrob Chemother. 2018 Sep 1;73(9):2584-2585. doi: 10.1093/jac/dky131. No abstract available.

PMID:
29659869
20.

Changing patterns of human migrations shaped the global population structure of Mycobacterium tuberculosis in France.

Barbier M, Dumitrescu O, Pichat C, Carret G, Ronnaux-Baron AS, Blasquez G, Godin-Benhaim C, Boisset S, Carricajo A, Jacomo V, Fredenucci I, Pérouse de Montclos M, Genestet C, Flandrois JP, Ader F, Supply P, Lina G, Wirth T, Rasigade JP.

Sci Rep. 2018 Apr 11;8(1):5855. doi: 10.1038/s41598-018-24034-6.

21.

Vaccination post-allogeneic hematopoietic stem cell transplantation: what is feasible?

Conrad A, Alcazer V, Valour F, Ader F; Lyon HEMINF Study Group.

Expert Rev Vaccines. 2018 Apr;17(4):299-309. doi: 10.1080/14760584.2018.1449649. Epub 2018 Mar 21. Review.

PMID:
29561216
22.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

23.

Pott's disease associated with large and multiple abscesses in a 30-year-old migrant from Chad.

Conrad A, Ferry T, Ader F, Valour F; Lyon BJI Study group.

BMJ Case Rep. 2018 Jan 29;2018. pii: bcr-2017-222420. doi: 10.1136/bcr-2017-222420. No abstract available.

PMID:
29378738
24.

Chronic disseminated candidiasis and acute leukemia: Impact on survival and hematopoietic stem cell transplantation agenda.

Grateau A, Le Maréchal M, Labussière-Wallet H, Ducastelle-Leprêtre S, Nicolini FE, Thomas X, Morisset S, Michallet M, Ader F; Lyon HEMINF study Group.

Med Mal Infect. 2018 May;48(3):202-206. doi: 10.1016/j.medmal.2017.12.004. Epub 2018 Jan 4.

PMID:
29307444
25.

Assessing the Combined Antibacterial Effect of Isoniazid and Rifampin on Four Mycobacterium tuberculosis Strains Using In Vitro Experiments and Response-Surface Modeling.

Genestet C, Ader F, Pichat C, Lina G, Dumitrescu O, Goutelle S.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01413-17. doi: 10.1128/AAC.01413-17. Print 2018 Jan.

26.

Outpatient parenteral antibiotic therapy: Evaluation of practices and limits of use in rural areas in France.

Triffault-Fillit C, Ferry T, Perpoint T, Adélaïde L, Le Ngoc Tho S, Ader F, Chidiac C, Valour F.

Med Mal Infect. 2018 Mar;48(2):130-135. doi: 10.1016/j.medmal.2017.09.008. Epub 2017 Oct 16.

PMID:
29050864
27.

High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutations: Authors' reply.

Richard P, Ader F.

Europace. 2018 Aug 1;20(8):1389. doi: 10.1093/europace/eux257. No abstract available.

PMID:
29036338
28.

Rare and unusual presentation of Cladophialophora infection in a pulmonary transplant cystic fibrosis patient.

Reynaud Q, Dupont D, Nove-Josserand R, Durupt S, Persat F, Ader F, Grenet D, Durieu I.

Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12789. Epub 2017 Nov 28.

PMID:
28994224
29.

Potential selection of genetically balanced spermatozoa based on the hypo-osmotic swelling test in chromosomal rearrangement carriers.

Rouen A, Carlier L, Heide S, Egloff M, Marzin P, Ader F, Schwartz M, Rogers E, Joyé N, Balet R, Lédée N, Prat-Ellenberg L, Cassuto NG, Siffroi JP.

Reprod Biomed Online. 2017 Oct;35(4):372-378. doi: 10.1016/j.rbmo.2017.06.017. Epub 2017 Jun 27.

PMID:
28711302
30.

Healthcare workers' knowledge, attitudes and practices relating to Ebola virus disease.

Valour F, Perpoint T, Gerbier-Colomban S, Ronin V, Potinet V, Le Loch JB, Ader F, Ferry T, Chidiac C.

J Hosp Infect. 2017 Sep;97(1):101-103. doi: 10.1016/j.jhin.2017.06.013. Epub 2017 Jun 15. No abstract available.

PMID:
28624632
31.

High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutations.

Thevenon J, Laurent G, Ader F, Laforêt P, Klug D, Duva Pentiah A, Gouya L, Maurage CA, Kacet S, Eicher JC, Albuisson J, Desnos M, Bieth E, Duboc D, Martin L, Réant P, Picard F, Bonithon-Kopp C, Gautier E, Binquet C, Thauvin-Robinet C, Faivre L, Bouvagnet P, Charron P, Richard P.

Europace. 2017 Apr 1;19(4):651-659. doi: 10.1093/europace/euw067.

PMID:
28431061
32.

Strain-specific estimation of epidemic success provides insights into the transmission dynamics of tuberculosis.

Rasigade JP, Barbier M, Dumitrescu O, Pichat C, Carret G, Ronnaux-Baron AS, Blasquez G, Godin-Benhaim C, Boisset S, Carricajo A, Jacomo V, Fredenucci I, Pérouse de Montclos M, Flandrois JP, Ader F, Supply P, Lina G, Wirth T.

Sci Rep. 2017 Mar 28;7:45326. doi: 10.1038/srep45326.

33.

Legionnaire's Disease in Compromised Hosts.

Lanternier F, Ader F, Pilmis B, Catherinot E, Jarraud S, Lortholary O.

Infect Dis Clin North Am. 2017 Mar;31(1):123-135. doi: 10.1016/j.idc.2016.10.014. Review.

PMID:
28159172
34.

Carbapenems and febrile neutropenia.

Alfandari S, Berthon C, Ader F.

Clin Microbiol Infect. 2017 Mar;23(3):212-213. doi: 10.1016/j.cmi.2016.12.016. Epub 2016 Dec 24. No abstract available.

35.

Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.

Peeters O, Ferry T, Ader F, Boibieux A, Braun E, Bouaziz A, Karsenty J, Forestier E, Laurent F, Lustig S, Chidiac C, Valour F; Lyon BJI study group.

BMC Infect Dis. 2016 Nov 3;16(1):622.

36.

Mycobacterium bovis prosthetic joint infection.

Langlois ME, Ader F, Dumistrescu O, Servien E, Saison J, Ferry T, Chidiac C, Valour F; Lyon BJI and TB study groups.

Med Mal Infect. 2016 Dec;46(8):445-448. doi: 10.1016/j.medmal.2016.07.005. Epub 2016 Sep 5. No abstract available.

PMID:
27609594
37.

Impact of anti-inflammatory drug consumption in peritonsillar abscesses: a retrospective cohort study.

Feasson T, Debeaupte M, Bidet C, Ader F, Disant F, Ferry T, Chidiac C, Valour F.

BMC Infect Dis. 2016 Aug 20;16(1):432. doi: 10.1186/s12879-016-1761-2.

38.

Multifocal melioidosis with femoral osteomyelitis in a healthy 25-year-old traveller.

Conrad A, Valour F, Ferry T, Ader F; Lyon BJI Study Group.

BMJ Case Rep. 2016 Jul 18;2016. pii: bcr2016216356. doi: 10.1136/bcr-2016-216356. No abstract available.

39.

Clinical Presentation, Diagnosis, and Bacterial Epidemiology of Peritoneal Tuberculosis in Two University Hospitals in France.

Cavalli Z, Ader F, Valour F, Saison J, Boussel L, Dumitrescu O, Perpoint T, Chidiac C, May T, Ferry T; Lyon TB Study group.

Infect Dis Ther. 2016 Jun;5(2):193-9. doi: 10.1007/s40121-016-0113-2. Epub 2016 Jun 13.

40.

Actinomycosis after allogeneic hematopoietic stem cell transplantation despite penicillin prophylaxis.

Barraco F, Labussière-Wallet H, Valour F, Ducastelle-Leprêtre S, Nicolini FE, Thomas X, Ferry T, Dumitrescu O, Michallet M, Ader F; Lyon HEMINF Study Group.

Transpl Infect Dis. 2016 Aug;18(4):595-600. doi: 10.1111/tid.12549. Epub 2016 Jul 5.

PMID:
27203624
41.

Interferon-γ Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection.

Valour F, Perpoint T, Sénéchal A, Kong XF, Bustamante J, Ferry T, Chidiac C, Ader F; Lyon TB study group.

Emerg Infect Dis. 2016 Jun;22(6):1124-1126. doi: 10.3201/eid2206.151860. Review. No abstract available.

42.

A matched case-control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complication.

Conrad A, Le Maréchal M, Dupont D, Ducastelle-Leprêtre S, Balsat M, Labussière-Wallet H, Barraco F, Nicolini FE, Thomas X, Gilis L, Chidiac C, Ferry T, Wallet F, Rabodonirina M, Salles G, Michallet M, Ader F; Lyon HEMINF study Group.

Clin Microbiol Infect. 2016 Jul;22(7):636-41. doi: 10.1016/j.cmi.2016.04.025. Epub 2016 May 10.

43.

Pharmacokinetic Variability of Daptomycin during Prolonged Therapy for Bone and Joint Infections.

Goutelle S, Roux S, Gagnieu MC, Valour F, Lustig S, Ader F, Laurent F, Chidiac C, Ferry T.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):3148-51. doi: 10.1128/AAC.02597-15. Print 2016 May.

44.

Daptomycin > 6 mg/kg/day as salvage therapy in patients with complex bone and joint infection: cohort study in a regional reference center.

Roux S, Valour F, Karsenty J, Gagnieu MC, Perpoint T, Lustig S, Ader F, Martha B, Laurent F, Chidiac C, Ferry T; Lyon BJI Study group.

BMC Infect Dis. 2016 Feb 17;16:83. doi: 10.1186/s12879-016-1420-7.

45.

Linezolid in the Starter Combination for Multidrug-Resistant Tuberculosis: Time to Move on to Group Four?

Grard S, Catho G, Valour F, Bouaziz A, Perpoint T, Braun E, Biron F, Miailhes P, Ferry T, Chidiac C, Souquet PJ, Couraud S, Lina G, Goutelle S, Veziris N, Dumitrescu O, Ader F.

Open Forum Infect Dis. 2015 Dec 22;2(4):ofv175. doi: 10.1093/ofid/ofv175. eCollection 2015 Dec.

46.

Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation.

Philippe M, Ranchon F, Gilis L, Schwiertz V, Vantard N, Ader F, Labussiere-Wallet H, Thomas X, Nicolini FE, Wattel E, Ducastelle-Leprêtre S, Barraco F, Lebras L, Salles G, Michallet M, Rioufol C.

Biol Blood Marrow Transplant. 2016 Apr;22(4):723-730. doi: 10.1016/j.bbmt.2015.12.009. Epub 2015 Dec 21.

47.

Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.

Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, Ullmann AJ, Dimopoulos G, Lange C; European Society for Clinical Microbiology and Infectious Diseases and European Respiratory Society.

Eur Respir J. 2016 Jan;47(1):45-68. doi: 10.1183/13993003.00583-2015.

48.

Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study.

Delsuc C, Cottereau A, Frealle E, Bienvenu AL, Dessein R, Jarraud S, Dumitrescu O, Le Maréchal M, Wallet F, Friggeri A, Argaud L, Rimmelé T, Nseir S, Ader F.

Crit Care. 2015 Dec 3;19:421. doi: 10.1186/s13054-015-1140-1.

49.

HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns.

Quintela A, Escuret V, Roux S, Bonnafous P, Gilis L, Barraco F, Labussière-Wallet H, Duscastelle-Leprêtre S, Nicolini FE, Thomas X, Chidiac C, Ferry T, Frobert E, Morisset S, Poitevin-Later F, Monneret G, Michallet M, Ader F; Lyon HEMINF Study Group.

J Infect. 2016 Feb;72(2):214-22. doi: 10.1016/j.jinf.2015.09.039. Epub 2015 Oct 28.

PMID:
26518057
50.

Asymptomatic prostatic tuberculous abscess in an immunocompetent 54-year-old man with peritoneal tuberculosis.

Cavalli Z, Ader F, Chidiac C, Ferry T; Lyon TB Study group.

BMJ Case Rep. 2015 Sep 3;2015. pii: bcr2015212342. doi: 10.1136/bcr-2015-212342. No abstract available.

Supplemental Content

Support Center